An efficient RCM-based synthesis of orthogonally protected meso-DAP and FK565

Journal of Organic Chemistry

Volumn 69, Issue 25, 2004, Pages 8946-8948

  Del Valle, Juan R ^a   Goodman, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CONDENSATION; DERIVATIVES; SYNTHESIS (CHEMICAL);

CHIRAL SYNTHONS; GLYCINE; MESO-2,6-DIAMINOPIMELIC ACID;

ORGANIC COMPOUNDS;

CROSS LINKING REAGENT; DIAMINOPIMELIC ACID; HEPTANOYL GAMMA DEXTRO GLUTAMYL 2,6 DIAMINOPIMELOYL DEXTRO ALANINE; IMMUNOSTIMULATING AGENT; PEPTIDOGLYCAN;

ARTICLE; CATALYST; CHEMICAL REACTION; CHEMICAL STRUCTURE; IMMUNOMODULATION; PROTON NUCLEAR MAGNETIC RESONANCE; RING CLOSING METATHESIS; RING OPENING; SYNTHESIS;

CYCLIZATION; DIAMINOPIMELIC ACID; MOLECULAR CONFORMATION; OLIGOPEPTIDES;

EID: 10044251319     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0485738     Document Type: Article

References (41)

1. (a) In Bacterial Cell Wall; Ghuysen, J.-M., Hakenbeck, R., Eds.; Elsevier Science BV: Amsterdam, 1994.
2. (b) Lazar, K.; Walker, S. Curr. Opin. Chem. Biol. 2002, 6, 786-793.
3. (c) Katz, A. H.; Caufield, C. E. Curr. Pharm. Des. 2003, 9, 857-866.
4. (d) van Heijenoort, J. Nat. Prod. Rep. 2001, 18, 503-519.
5. (e) van Heijenoort, J. Glycobiology 2001, 11, 25R-36R.
6. Patte, J.-C. In Amino Acids: Biosynthesis and Genetic Regulation; Herrmann, K. M., Somerville, R. L., Eds.; Addison-Wesley: Reading, MA, 1983.
7. (a) Johannsen, L.; Wecke, J.; Obal, F.; Krueger, J. M. Am. J. Phys. 1991, 260, R126-R133.
8. (b) Luker, K. E.; Tyler, A. N.; Marshall, G. R.; Goldman, W. E. Mol. Microbiol. 1995, 16, 733-743.
9. (c) Takada, H.; Kawabata, Y.; Kawata, S.; Kusumoto, S. Infect. Immun. 1996, 64, 657-659.
10. (d) Gotoh, T.; Nakahara, K.; Iwami, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1982, 35, 1280-1285.
11. (e) Hemmi, K.; Takeno, H.; Okada, S.; Nakaguchi, O.; Kitaura, Y.; Hashimoto, M. J. Am. Chem. Soc. 1981, 103, 7026-7028.
12. (f) Kitaura, Y.; Nakaguchi, O.; Takeno, H.; Okada, S.; Yonishi, S.; Hemmi, K.; Mori, J.; Senoh, H.; Mine, Y.; Hashimoto, M. J. Med. Chem. 1982, 25, 335-337.
13. (g) Gotoh, T.; Nakahara, K.; Nishiura, T.; Hashimoto, M.; Kino, T.; Kuroda, Y.; Okuhara, M.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1982, 35, 1286-1292.
14. For examples of DAP derivative syntheses based on asymmetric alkylations, see: (a) Williams, R. M.; Yuan, C. G. J. Org. Chem. 1992, 57, 6519-6527.
15. (b) Williams, R. M.; Yuan, C. G. J. Org. Chem. 1994, 59, 6190-6193.
16. (c) Jurgens, A. R. Tetrahedron Lett. 1992, 33, 4727-4730.
17. (d) Paradisi, F.; Porzi, G.; Sandri, S. Tetrahedron: Asymmetry 2001, 12, 3319-3324.
18. For examples of DAP derivative syntheses based on chiral catalysis, see: (a) Wang, W.; Xiong, C. Y.; Yang, J. Q.; Hruby, V. J. Synthesis (Stuttgart) 2002, 94-98.
19. (b) Collier, P. N.; Campbell, A. D.; Patel, I.; Taylor, R. J. K. Tetrahedron 2002, 58, 6117-6125.
20. (c) Collier, P. N.; Patel, I.; Taylor, R. J. K. Tetrahedron Lett. 2001, 42, 5953-5954.
21. (d) Sutherland, A.; Vederas, J. C. Chem. Commun. 2002, 224-225.
22. (e) Gao, Y.; Lane-Bell, P.; Vederas, J. C. J. Org. Chem. 1998, 63, 2133-2143.
23. (f) Davis, F. A.; Srirajan, V. J. Org. Chem. 2000, 65, 3248-3251.
24. (g) Hernandez, N.; Martin, V. S. J. Org. Chem. 2001, 66, 4934-4938.
25. (h) Roberts, J. L.; Chan, C. Tetrahedron Lett. 2002, 43, 7679-7682.
26. (a) The groups of Vederas and Williams have investigated the use of RCM in the synthesis of differentially protected 2,7-diaminosuberic acid derivatives.
27. See ref 5e and (b) Williams, R. M.; Liu, J. W. J. Org. Chem. 1998, 63, 2130-2132.
28. Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K. Synthesis (Stuttgart) 1998, 1707-1709.
29. Burk, M. J.; Allen, J. G. J. Org. Chem. 1997, 62, 7054-7057.
30. (a) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. Chem., Int. Ed. Engl. 1995, 34, 2039-2041.
31. (b) Nguyen, S. T.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1993, 115, 9858-9859.
32. Creighton, C. J.; Reitz, A. B. Org. Lett. 2001, 3, 893-895.
33. Zhao, M. Z.; Li, J.; Mano, E.; Song, Z. G.; Tschaen, D. M.; Grabowski, E. J. J.; Reider, P. J. J. Org. Chem. 1999, 64, 2564-2566.
34. See the Supporting Information.
35. (a) Sone, S.; Mutsuura, S.; Ishii, K.; Shirahama, T.; Tsubura, E. Gann 1984, 75, 920-928.
36. (b) Inamura, N.; Nakahara, K.; Kino, T.; Gotoh, T.; Kawamura, I.; Aoki, H.; Imanaka, H.; Sone, S. J. Biol. Response Modif. 1985, 4, 408-417.
37. (c) Hemmi, K.; Aratani, M.; Takeno, H.; Okada, S.; Miyazaki, Y.; Nakaguchi, O.; Kitaura, Y.; Hashimoto, M. J. Antibiot. 1982, 35, 1300-1311.
38. (d) Yokota, Y.; Mine, Y.; Wakai, Y.; Watanabe, Y.; Nishida, M.; Goto, S.; Kuwahara, S. J. Antibiot. 1983, 36, 1051-1058.
39. Yokota, Y.; Wakai, Y.; Watanabe, Y.; Mine, Y. J. Antibiot. 1988, 41, 1479-1487.
40. Kolodziejczyk, A. M.; Kolodziejczyk, A. S.; Stoev, S. Int. J. Pept. Protein Res. 1992, 39, 382-387.
41. See the Supporting Information for the preparative procedure.